Cardiovascular Systems, Inc. Presents New Late-Breaking Coronary Results at EuroPCR Conference
5/23/2013 11:14:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented 30-day results from its ORBIT II study of coronary artery disease in a late-breaking presentation at the 2013 European Association of Percutaneous Cardiovascular Interventions (EuroPCR) conference in Paris.
Help employers find you! Check out all the jobs and post your resume.